FDA Approves Video Game Based on UCSF Brain Research as ADHD Therapy for Kids

The U.S. Food and Drug Administration has approved the first video game therapeutic as a treatment for attention deficit hyperactivity disorder (ADHD) in children, based on research by UC San Francisco’s Adam Gazzaley, MD, PhD.

Gazzaley concluded that these adults’ improved performance after playing the game was due to enhanced function in a brain network involved in cognitive control, which is necessary to pursue goals. With the new FDA approval, children can now be treated with a kids’ version of the technology, called EndeavorRX. Gazzaley is a co-founder of Akili Interactive, which produces EndeavorRx, and which conducted pivotal clinical trials of the game as an ADHD treatment with researchers at Duke University and elsewhere.

https://www.ucsf.edu/news/2020/06/417841/fda-approves-video-game-based-ucsf-brain-research-adhd-therapy-kids